Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 13, 2025Open Access

Structural basis for chemotype diversity in small molecule GLP-1 receptor agonist drug discovery

View Full Paper
Ask AI
Bookmark
Share

Authors

FWFan WuDSDanfeng SongWHWei Huang

Discussion

Loading...

Member takes

Overview

Analysis reveals distinct binding modes of GLP-1R agonists, suggesting innovative drug discovery strategies.

Key Points

  • Novel insights into GLP-1 small molecule agonist mechanisms may transform drug design strategies.
  • High-resolution cryo-EM structures showcase how diverse binding modes enhance understanding of GLP-1R activation.
  • The newly proposed GPCR nomenclature aids in comprehending varied receptor conformations and drug development.
  • Understanding structural variations may improve patient compliance and treatment effectiveness for obesity-related conditions.

Cite This Study

Wu et al. (2025) studied this question.

synapsesocial.com/papers/68ed1896f29694dd1da78debhttps://doi.org/10.21203/rs.3.rs-7597307/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In Silico discovery and design of molecular glues as a new strategy for development of non-peptidic, small-molecule agonists of GLP-1 receptor2025
  2. 2Exploring Conformational Transitions in Biased and Balanced Ligand Binding of GLP-1R2025
  3. 3"Next-in-class" GLP-1R Danuglipron- and Lotiglipron-like Agonists: A Patent Review (2020-2024)2025
  4. 4Computational assessment of the dimeric incretin GLP-1cpGLP-1 reveals the structural bases for its activity2025
  5. 5Strategic Design of Triple GLP-1R/GCGR/GIPR Agonists with Varied Receptor Potency: Achieving Comparable Glycemic and Weight Reduction Effects2025